邦费罗尼校正
子群分析
结果(博弈论)
人口
多重比较问题
中期分析
计算机科学
I类和II类错误
统计
选择(遗传算法)
临床试验
功能(生物学)
字错误率
计量经济学
数学
医学
机器学习
人工智能
内科学
生物
置信区间
数理经济学
进化生物学
环境卫生
作者
Tim Friede,Nick Parsons,Nigel Stallard
摘要
Growing interest in personalised medicine and targeted therapies is leading to an increase in the importance of subgroup analyses. If it is planned to view treatment comparisons in both a predefined subgroup and the full population as co‐primary analyses, it is important that the statistical analysis controls the familywise type I error rate. Spiessens and Debois (Cont. Clin. Trials, 2010, 31, 647–656) recently proposed an approach specific for this setting, which incorporates an assumption about the correlation based on the known sizes of the different groups, and showed that this is more powerful than generic multiple comparisons procedures such as the Bonferroni correction. If recruitment is slow relative to the length of time taken to observe the outcome, it may be efficient to conduct an interim analysis. In this paper, we propose a new method for an adaptive clinical trial with co‐primary analyses in a predefined subgroup and the full population based on the conditional error function principle. The methodology is generic in that we assume test statistics can be taken to be normally distributed rather than making any specific distributional assumptions about individual patient data. In a simulation study, we demonstrate that the new method is more powerful than previously suggested analysis strategies. Furthermore, we show how the method can be extended to situations when the selection is not based on the final but on an early outcome. We use a case study in a targeted therapy in oncology to illustrate the use of the proposed methodology with non‐normal outcomes. Copyright © 2012 John Wiley & Sons, Ltd.
科研通智能强力驱动
Strongly Powered by AbleSci AI